期刊文献+

MMP-9、LMP-1蛋白在鼻咽癌中的表达及其与远处转移的相关性研究 被引量:3

The expression of matrix metalloproteinase-9 and latent membrane protein-1 with metastasis in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的:研究基质金属蛋白酶-9(MMP-9)、潜伏膜蛋白-1(LMP-1)在鼻咽癌中的表达及其对鼻咽癌远处转移的影响。方法:收集83例鼻咽癌患者的临床资料及鼻咽部瘤体活检组织蜡块。采用免疫组化S-P法检测标本中MMP-9、LMP-1的表达。结果:MMP-9阳性表达率为65%(54/83),其表达与颈淋巴结转移、远处转移关系密切(P<0.05)。LMP-1阳性表达率为57%(47/83),其表达与颈淋巴结转移、远处转移关系密切(P<0.05);且与MMP-9表达呈显著正相关(rs=0.327,P<0.05)。鼻咽癌远处转移的危险因素是临床分期(Ⅲ、Ⅳ期)、颈淋巴结N3阳性、MMP-9阳性表达、LMP-1阳性表达(P<0.05)。MMP-9、LMP-1均为阳性表达者远处转移风险更高(P<0.05)。结论:MMP-9、LMP-1阳性表达与远处转移明显相关,可作为鼻咽癌远处转移的预测指标。 Objective: To assess the relation of expression of matrix metalloproteinase - 9 ( MMP - 9 ) and latent membrane protein- 1 (LMP- 1 ) with metastasis in nasopharyngeal carcinoma(NPC). Methods:The expressions of MMP -9 and LMP - 1 were immunohistochemically examined in 83 NPC section. Results: The positive expression rate of MMP- 9 was 65%, correlated with lymph node metastasis, distant metastasis (P 〈 0.05 ). The positive expres- sion rate of LMP - 1 was 57% ,correlated with lymph node metastasis,distant metastasis(P 〈0.05). The expression of MMP - 9 showed a significant positive correction with the expression of LMP - 1 ( r = 0. 327, P 〈 0.05 ). The factor predicting distant metastasis in NPC was stage ( Ⅲ,Ⅳ ), N3, positive expression of MMP - 9 and LMP - 1. Conclusion: MMP - 9 and LMP - 1 are highly expressed in NPG, can be used as predictor of distant metastasis.
出处 《现代肿瘤医学》 CAS 2009年第12期2283-2286,共4页 Journal of Modern Oncology
基金 广西科技攻关项目(编号:0322025-5)
关键词 鼻咽癌 基质金属蛋白酶-9 潜伏膜蛋白-1 远处转移 免疫组化 nasopharyngeal neoplasms matrix metalloproteinase - 9 iatent membrane protein - 1 metastasis immu-nohistochemistry
  • 相关文献

参考文献12

二级参考文献48

  • 1[3]Miller WE,Cheshire JL,Baldwin AS Jr.The NPC derived C1 5LMP1 protein confers enhanced activation of NF-Kappa B and induction of the EGFR in epithelial cells. Oncogene, 1998, 16(14): 1869~1877.
  • 2[4]Millere WE, Earp HS, Raab TN. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptro. J Virol, 1995, 69 (7): 4390.
  • 3[5]Fahracus S, Rymo L, Rhem JS, et al. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature, 1990, 345: 447.
  • 4[6]Spruch CH, Tsai YC, Huang DP, et al. Absence of P53 gene mutations in primary nasopharygeal carcinomas. Cancer Res,1992, 52: 4787~4790.
  • 5[7]Sheu LF, Chen A, Tseng HH, et al. Expression of P53 protein in nasopharyngeal carcinomas. J pathol, 1994, 172: 294~296.
  • 6[8]Furukawa M, Nagayama I, Murono S, et al. Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas. Rinsho Byori, 1996, (9): 832~837.
  • 7黄腾波,汪慧民,李景廉,欧星泰,方积乾,刘克拉.鼻咽癌高危人群、癌前病变的确立[J].癌症,1997,16(2):81-84. 被引量:33
  • 8David E, Kleine R, William G, et al. Matrix metallproteinases and metastasis[J]. Cancer Chemother Pharmacol,1999,43:42-51.
  • 9Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease[J]. Biological Chemistry Hoppe Seyler, 1995, 376(6):345- 355.
  • 10Sang QX, Birkeda-hansen H, Vanwart HE. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B[J]. Biochim Biophys Acta, 1995, 1251(2): 99-108.

共引文献60

同被引文献22

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部